Jury Clears Armistice Capital, Execs Of Securities Fraud
A California federal jury on Tuesday cleared Armistice Capital and two of its executives on class action claims it pumped and dumped $250 million in Vaxart stock during the COVID-19 pandemic...To view the full article, register now.
Already a subscriber? Click here to view full article